Published in Ann Neurol on January 01, 1992
Cognitive Impairment in Parkinson's Disease: Is It a Unified Phenomenon? Brain Impair (2005) 0.81
Dopaminergic effects on the implicit processing of distractor objects in Parkinson's disease. Exp Brain Res (2000) 0.78
Leakage of decision uncertainty into movement execution in Parkinson's disease? Exp Brain Res (2013) 0.76
Commentary. J Neurosci Rural Pract (2014) 0.75
A longitudinal study of drivers with Alzheimer disease. Neurology (2008) 3.17
Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol Psychiatry (2004) 1.76
Gender-related clinical differences in older patients with schizophrenia. J Clin Psychiatry (1999) 1.49
Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations. Neurology (1990) 1.38
Hippocampal pathologic findings in schizophrenia. A morphometric study. Arch Gen Psychiatry (1989) 1.21
Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. The HNRC Group. J Clin Exp Neuropsychol (1994) 1.20
Conventional vs. newer antipsychotics in elderly patients. Am J Geriatr Psychiatry (1999) 1.18
Memory systems in normal and pathological aging. Curr Opin Neurol (1994) 1.17
Did schizophrenia exist before the eighteenth century? Compr Psychiatry (1986) 1.11
Parkinsonism in neuroleptic-naive schizophrenic patients. Am J Psychiatry (1993) 1.07
A single-photon emission computed tomography imaging study of driving impairment in patients with Alzheimer's disease. Dement Geriatr Cogn Disord (2000) 1.06
High prevalence of visual hallucinations in research subjects with chronic schizophrenia. Am J Psychiatry (1989) 1.05
New pathway for delta-aminolevulinic acid biosynthesis: formation from alpha-ketoglutaric acid by two partially purified plant enzymes. Biochem Biophys Res Commun (1976) 1.03
Differential decline in word generation from phonemic and semantic categories during the course of Alzheimer's disease: implications for the integrity of semantic memory. J Int Neuropsychol Soc (1999) 1.02
Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatry (1993) 0.99
Gender, estrogen, and schizophrenia. Psychopharmacol Bull (1997) 0.97
Neuroanatomical studies of major affective disorders. A review and suggestions for further research. Br J Psychiatry (1988) 0.96
Differentiation of Alzheimer's disease and Huntington's disease with the Dementia Rating Scale. Arch Neurol (1989) 0.96
Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study. Curr Pharmacogenomics Person Med (2009) 0.92
Reliability of an instrumental assessment of tardive dyskinesia: results from VA Cooperative Study #394. Psychopharmacology (Berl) (1997) 0.91
Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia. Acta Psychiatr Scand (1994) 0.90
Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E. Ann N Y Acad Sci (1989) 0.88
The role of psychiatrists in primary care of patients with severe mental illness. Psychiatr Serv (2000) 0.87
Quantifying drug-induced changes in parkinsonian rigidity using an instrumental measure of activated stiffness. Clin Neuropharmacol (1992) 0.85
A disturbance in the control of muscle force in neuroleptic-naive schizophrenic patients. Biol Psychiatry (1994) 0.85
Gender differences in the behavioral manifestations of Alzheimer's disease. J Am Geriatr Soc (1996) 0.85
Scaling of movement velocity: a measure of neuromotor retardation in individuals with psychopathology. Psychophysiology (1998) 0.84
Cerebellar pathology in schizophrenia? A neuronometric study. Biol Psychiatry (1986) 0.84
Hippocampal pyramidal cells and aging in the human: a quantitative study of neuronal loss in sectors CA1 to CA4. Exp Neurol (1986) 0.83
Decline in working memory associated with HIV infection. HNRC Group. Psychol Med (1995) 0.82
Retrograde amnesia in patients with Alzheimer's disease or Huntington's disease. Neurobiol Aging (1988) 0.82
Portable device for quantifying parkinsonian wrist rigidity. Mov Disord (1994) 0.82
An association between increased serum-soluble interleukin-2 receptors and a disturbance in muscle force in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry (1997) 0.81
Dispositional correlates of hypnosis: a phenomenological approach. Int J Clin Exp Hypn (1989) 0.81
Worsening of postural tremor in patients with levodopa-induced dyskinesia: a quantitative analysis. Clin Neuropharmacol (1993) 0.81
Specificity of the memory deficits associated with basal ganglia dysfunction. Rev Neurol (Paris) (1995) 0.80
Recognition and treatment of depression in Alzheimer's disease. Geriatrics (1989) 0.80
A treatment outcome study of community-based residential care. Hosp Community Psychiatry (1994) 0.80
Alpha-tocopherol in tardive dyskinesia. Lancet (1987) 0.79
Diazepam for catatonia. Am J Psychiatry (1984) 0.78
A potential mechanism underlying the voluntary suppression of tardive dyskinesia. J Psychiatr Res (1989) 0.78
Study of neuropathologic changes in the striatum following 4, 8 and 12 months of treatment with fluphenazine in rats. Psychopharmacology (Berl) (1992) 0.78
Hormone replacement therapy in postmenopausal women with schizophrenia: positive effect on negative symptoms? Biol Psychiatry (2001) 0.77
Subtle signs of prenatal maldevelopment of the hand ectoderm in schizophrenia: a preliminary monozygotic twin study. Biol Psychiatry (1991) 0.77
Extrapyramidal motor abnormalities associated with late-life psychosis. Schizophr Bull (1993) 0.77
Lateralized cortical perfusion in women with Alzheimer's disease. J Gend Specif Med (2001) 0.77
Fine force instability: a quantitative measure of neuroleptic-induced dyskinesia in the hand. J Neuropsychiatry Clin Neurosci (1990) 0.77
Adverse neurobiological effects of long-term use of neuroleptics: human and animal studies. J Psychiatr Res (1998) 0.77
Comparison of outcomes of acute care in short-term residential treatment and psychiatric hospital settings. Psychiatr Serv (1999) 0.76
Transient grasp reflexes in schizophrenia. Biol Psychiatry (1985) 0.76
Pharmacological treatments of tardive dyskinesia in the 1980s. J Clin Psychopharmacol (1988) 0.76
Clinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia. Biol Psychiatry (1991) 0.76
Cerebrospinal fluid and serum levels of neuron-specific enolase in patients with schizophrenia. Psychiatry Res (1992) 0.76
Methodological considerations in estimating speed of cognitive operations. J Int Neuropsychol Soc (1995) 0.76
Effects of alcohol on symptoms in alcoholic and nonalcoholic patients with schizophrenia. Hosp Community Psychiatry (1994) 0.75
Instrumental evidence that age increases motor instability in neuroleptic-treated patients. J Gerontol (1991) 0.75
Surgery for Parkinson's disease: is the graft really necessary? J Neuropsychiatry Clin Neurosci (1989) 0.75
Increased cerebrospinal fluid cyclo(His-Pro) content in schizophrenia. Neuropeptides (1991) 0.75
Pharmacists' role in clozapine therapy at a Veterans Affairs medical center. Am J Hosp Pharm (1994) 0.75
Fluctuation of tardive dyskinesia. Biol Psychiatry (1995) 0.75
Self-perception of tardive dyskinesia and neuroleptic-induced parkinsonism: a study of clinical correlates. Psychopharmacol Bull (1987) 0.75
Asymmetry of neuroleptic-induced rigidity: development of quantitative methods and clinical correlates. Psychiatry Res (1989) 0.75
Relationship of gender and age at onset of schizophrenia to severity of dyskinesia. J Neuropsychiatry Clin Neurosci (2001) 0.75
Instrumental motor predictors of neuroleptic-induced parkinsonism in newly medicated schizophrenia patients. J Neuropsychiatry Clin Neurosci (1997) 0.75
The biasing effect of verbal labels on memory for ambiguous figures in patients with progressive dementia. J Int Neuropsychol Soc (1995) 0.75